Parkinson's Disease Inflammatory Biomarker Profiling
common.study.values.description
“Parkinson's Disease Inflammatory Biomarker Profiling”
This study compares a comprehensive panel of immunological biomarkers between Parkinson's disease patients and healthy, environmentally matched participants. This unique study design provides the ability to control for differences in environment between study subjects. The goal of this study is to 1) identify a specific set of immunological markers that correlate with a clinical diagnosis of Parkinson's disease and 2) stratify patients by disease severity using these same biomarkers.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Diagnostic Test - LBT-3627
Immunomodulatory agent
Diagnostic Test - Immunological profiling
Comprehensive profiling of inflammatory and anti-inflammatory markers (incl. cellular, molecular) including cellular functional assays
participant.views.study.view.additional
participant.views.study.view.scientific-title
Inflammatory Parkinson's Disease (PD) Clinical Biomarker Profiling in T Cells
common.study.values.clinical-trial-id
NCT03633513
participant.views.study.view.id
b4xRVb
